making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
In the past 2 decades, opioid use disorder (OUD) cost over half a million lives in the US alone, fueled by unethical practices from several drugmakers. Coming off opioid medication is a painful, […]
Shortly after Catalyst Biosciences closed its deal with Vertex, shareholders have come forward expressing that it was too little, too late. Catalyst sold its preclinical complement drugs to Vertex […]
Register for Informa Connect’s Patient Support Services Congress today, May 27th, to save $100! The conference takes place online and in-person in Philadelphia, PA from November 8-10. Professionals […]
Virtual medical conferences stepped in during a time that live networking events weren’t possible. Are they still the answer for the medical community? More than two years into the Covid-19…
“Have you read this?” my husband leans across the breakfast table, jabbing at an article he is reading. “No dear” I respond, “you haven’t shared the paper this morning” “Apparently”…
Affective disorders also known as mood disorders are a set of mental disorders that seriously impact a person’s mental state, how they do things, how they go about life and…
Anaemia (commonly spelt anemia in North America), refers to the medical condition in which the body doesn’t have enough functioning red blood cells to adequately carry oxygen to all areas…
What is market access and what makes market access a great career choice? As the final hurdle in the drug development process, market access is a driving force behind the…
It’s estimated that in 2019, nearly 500,000 deaths were caused by asthma – a noncommunicable disease that affects the airways by narrowing them, causing them to swell and sometimes producing…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.
